SpyGlass To Boost Ophthalmic Drug Adherence With Intraocular Delivery Platform

After $90m Series C

Emerging Company Profile: SpyGlass Pharma
SpyGlass' Drug-Eluting Pads Are Attached To The Haptics Of The Lens • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Emerging Company Profiles

More from Start-Ups & SMEs